Ling Liu
Nanning, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
IL-32 as a potential biomarker and therapeutic target in cardiovascular disease.
Journal: Frontiers in immunology
Published: November 27, 2025
Modularized Cathode with Neural Network Topology for High Rate and Fault-Tolerant Lithium-Sulfur Batteries.
Journal: Advanced materials (Deerfield Beach, Fla.)
Published: March 12, 2025
Prognostic Value of D-Dimer in Acute Type A Aortic Dissection and Intramural Hematoma: Observations from the Acute Aortic Syndrome Group of the Registry of Acute Non-Traumatic Chest Pain in China.
Journal: Journal of the American Heart Association
Published: January 16, 2025
Prevalence and prognostic impact of abnormal left ventricular ejection fraction in Hemodialysis patients with end-stage renal disease.
Journal: BMC nephrology
Published: November 25, 2024
Retraction notice to "Interleukin-22 deficiency alleviates doxorubicin-induced oxidative stress and cardiac injury via the p38 MAPK/macrophage/Fizz3 axis in mice" [Redox Biol. 36 (2020) 101636].
Journal: Redox biology
Published: September 19, 2024
Gender disparities in patients treated with veno-arterial ECMO for cardiogenic shock complicating acute myocardial infarction.
Journal: Frontiers in cardiovascular medicine
Published: July 08, 2024
In silico analysis and verification of critical genes related to vascular calcification in multiple diseases.
Journal: Cell biochemistry and function
Published: May 09, 2023
Enlarged Interlayer Spacing of Marigold-Shaped 1T-MoS2 with Sulfur Vacancies via Oxygen-Assisted Phosphorus Embedding for Rechargeable Zinc-Ion Batteries.
Journal: Nanomaterials (Basel, Switzerland)
Published: February 26, 2023
Corrigendum to "Anti-Interleukin-16-Neutralizing Antibody Attenuates Cardiac Inflammation and Protects against Cardiac Injury in Doxorubicin-Treated Mice".
Journal: Mediators of inflammation
Published: April 06, 2022
Secreted frizzled-related protein 4 exerts anti-atherosclerotic effects by reducing inflammation and oxidative stress.
Journal: European journal of pharmacology
Published: December 04, 2021
Last Updated: 09/26/2026